Founder, Managing Director

DR.MARK Laboratories is founded by a Scientific Research Professional with nearly two decades of expertise-Dr.Markandeya Bekkam, Ph.D. Backed by his diverse and varied research, including the exponential work in the field of Synthetic Organic Chemistry & Process Development Chemistry, he is ably aided by a talented team of scientists.

Prior to the founding of the company, Dr. Bekkam has worked in a leading API Company-MSN Laboratories Pvt. Ltd., Hyderabad for more than a decade, wherein he has been involved in API’s process development, Technology Transfer, Process validation, and supporting Drug Master File (DMF) submissions. He also played a pivotal role in resolving DMF deficiencies for a broad spectrum of APIs and intermediates across multiple therapeutic areas. He earned his Ph.D in Organic Chemistry from Indian Institute of Chemical Technology (IICT), Hyderabad, India under the guidance of Dr. G. Kumaraswamy. His Doctoral studies mainly focused on the Synthesis of Natural and Unnatural Beta Lactone Peptide Molecules and their Stereo chemical studies towards anti-tumor activity.

Dr. Bekkam went on to conduct Postdoctoral Research at Mississippi State University, USA, under the mentorship of Dr. Keith T. Mead for over a year. During this tenure, he made notable contributions to the total synthesis of the Calyxin family of natural products and advanced the Diels–Alder methodology. He subsequently joined the laboratory of Prof. David E. Nichols at Purdue University, USA, for nearly two years, where his research focused on medicinal chemistry. His work led to significant innovations in the design and synthesis of focused compound libraries, including thiazole, imidazole, tetrazoloquinoxaline, pyrimidothiazothione, and octahydrobenzo[f]quinoline scaffolds, targeting neurological diseases.

He has more than 25 National and International Patents, including Research Publications, to his credit.